Open | - |
Close | - |
Volume / Avg. | 510.000 / 122.344K |
Day Range | - - - |
52 Wk Range | 31.860 - 45.210 |
Market Cap | $2.204B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 26 |
Short Interest | % |
Days to Cover | 17.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Galapagos (NASDAQ: GLPG) through any online brokerage.
Other companies in Galapagos’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Syndax Pharmaceuticals (NASDAQ:SNDX), PTC Therapeutics (NASDAQ:PTCT) and TG Therapeutics (NASDAQ:TGTX).
The latest price target for Galapagos (NASDAQ: GLPG) was reported by Morgan Stanley on Thursday, March 7, 2024. The analyst firm set a price target for 38.00 expecting GLPG to rise to within 12 months (a possible 13.60% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Galapagos (NASDAQ: GLPG) is $33.45 last updated Today at March 19, 2024 at 5:12 AM EDT.
There are no upcoming dividends for Galapagos.
Galapagos’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Galapagos.
Galapagos is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.